Most read article(s)

Views & Reviews
Presentations and mechanisms of CNS disorders related to COVID-19
Marta Bodro, Yaroslau Compta, Raquel Sánchez-Valle

December 11, 2020
Article
Pilot study of a ketogenic diet in relapsing-remitting MS
J. Nicholas Brenton, Brenda Banwell, A.G. Christina Bergqvist, et al.

April 12, 2019
Article
Potential Role of CHI3L1+ Astrocytes in Progression in MS
Laura Cubas-Núñez, Sara Gil-Perotín, Jéssica Castillo-Villalba, et al.

March 03, 2021
Article
Human Herpesvirus 6 Encephalitis in Immunocompetent and Immunocompromised Hosts
Giulia Berzero, Giulia Campanini, Elisa Vegezzi, et al.

January 12, 2021
Article
Defining Benign/Burnt-Out MS and Discontinuing Disease-Modifying Therapies
Derek McFaul, Nektar N. Hakopian, Jessica B. Smith, et al.

February 08, 2021
Article
Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis
Tomas Uher, Jan Krasensky, Charles Malpas, et al.

March 16, 2021
Article
B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis
Sabine Tacke, Stefan Braune, Damiano M. Rovituso, et al.

March 11, 2021
Article
Guillain-Barré Syndrome Outbreak in Peru 2019 Associated With Campylobacter jejuni Infection
Ana P. Ramos, Sonja E. Leonhard, Susan K. Halstead, et al.

February 05, 2021
Article
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS
José I. Fernández-Velasco, Jens Kuhle, Enric Monreal, et al.

January 06, 2021
Article
Mass Cytometry of CSF Identifies an MS-Associated B-cell Population
David Johansson, Céline Rauld, Julien Roux, et al.

February 15, 2021

Pages